Leidos Wins $2.7 Billion U.S. Army Contract to Accelerate Hypersonic Weapons Production
LDOS is trading near its 52-week low of $125.34 (1.2% above the low) on light trading volume (0.4× avg).
Summary
Leidos has been awarded a significant $2.7 billion contract by the U.S. Army to transition hypersonic weapons programs from prototyping to production. This substantial award unifies the Thermal Protection Shield (TPS) and Common Hypersonic Glide Body (CHGB) programs, aiming to streamline development and accelerate delivery of critical defense capabilities. This contract is highly material, representing a significant revenue stream and strengthening Leidos' strategic position in advanced defense technologies, following other recent contract wins and strong first-quarter results. The award provides substantial backlog and aligns with the company's long-term growth strategy, serving as a strong positive catalyst for the stock, particularly as it trades near its 52-week low. Traders will be watching for execution details and potential follow-on awards in this critical defense sector.
At the time of this announcement, LDOS was trading at $126.82 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $16B. The 52-week trading range was $125.34 to $205.77. This news item was assessed with positive market sentiment and an importance score of 9 out of 10. Source: PR Newswire.